Cardiology

Top Story

Two biomarkers yield comparable CV risk prediction before, during sacubitril/valsartan treatment

Two biomarkers yield comparable CV risk prediction before, during sacubitril/valsartan treatment
March 18, 2019

Read the Perspective from Gregg C. Fonarow, MD

Meeting NewsPerspective

CV benefits of diabetes drug dapagliflozin extend to patients with reduced ejection fraction

March 18, 2019
NEW ORLEANS — Treatment with the SGLT2 inhibitor dapagliflozin reduced HF hospitalizations in patients with a broad range of left ventricular ejection fraction and…
Meeting NewsPerspective

Combination therapy with amlodipine effective in sub-Saharan black adults

March 18, 2019
NEW ORLEANS — A combination of amlodipine and one of hydrochlorothiazide or perindopril showed efficacy in treating hypertension in black adults in sub-Saharan…
Meeting NewsPerspective

MOMENTUM 3: Newer LVAD ‘adds life to patients’ years’

March 18, 2019
NEW ORLEANS — In the final results of the MOMENTUM 3 trial, patients with advanced HF requiring a left ventricular assist device implanted with a continuous…
Meeting NewsPerspective

Bempedoic acid shows promise for LDL lowering in high-risk patients

March 18, 2019
NEW ORLEANS — Treatment with bempedoic acid, an investigational oral, once-daily therapy that is designed to work in the liver to inhibit cholesterol biosynthesis…
More Headlines »
CME ABIM MOC

Ace the Case: A 68-Year-Old Man with Cough and Dyspnea on Exertion

There is no commercial support for this activity.

This educational activity will use a case study to discuss the management of a 68-year-old man with cough and dyspnea…
More »
Video
Meeting News

VIDEO: ‘Next level of education’ offered at ISET

February 8, 2019
More »
Resource Centers
American College of Cardiology Annual Scientific Session

American College of Cardiology Annual Scientific Session

Video
Meeting News

VIDEO: A fellow's reaction to hands-on learning at TCT 2018

October 14, 2018
More »